Assessment of Use and Safety of Edaravone for Amyotrophic Lateral Sclerosis in the Veterans Affairs Health Care System

IMPORTANCE: Using real-world data, the US Department of Veterans Affairs (VA) initiated a surveillance evaluation of edaravone after its approval for amyotrophic lateral sclerosis (ALS) in 2017. The use and safety of edaravone for patients with ALS in the VA health care system remain to be assessed....

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JAMA Netw Open
Главные авторы: Vu, Michelle, Tortorice, Kathryn, Zacher, Jennifer, Dong, Diane, Hur, Kwan, Zhang, Rongping, Good, Chester B., Glassman, Peter A., Cunningham, Francesca E.
Формат: Artigo
Язык:Inglês
Опубликовано: American Medical Association 2020
Предметы:
Original Investigation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7536587/
https://ncbi.nlm.nih.gov/pubmed/33017028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2020.14645
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы